Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Obtech Medical was a Swiss medical device company focused on developing minimally invasive surgical treatments for morbid obesity. Its primary product, the Swedish Adjustable Gastric Band (SAGB), became a leading laparoscopic solution for weight loss surgery globally. The company was acquired by Ethicon Endo-Surgery, a Johnson & Johnson company, in 2002 to expand their bariatric surgery portfolio. This acquisition allowed Johnson & Johnson to compete directly in the adjustable gastric band market against competitors like BioEnterics. The SAGB technology was integrated into Ethicon's global distribution network, significantly increasing its clinical adoption. The device works by creating a small gastric pouch to limit food intake and induce satiety.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Obtech Medical.